Abstract
The UPLC MS/MS analysis showed the presence of the two antibiotics in the pharmaceutical industry discharges during 3 months; norfloxacin and spiramycin which were quantified with the mean concentrations of 226.7 and 84.2 ng mL−1, respectively. Sixteen resistant isolates were obtained from the pharmaceutical effluent and identified by sequencing. These isolates belong to different genera, namely Citrobacter, Acinetobacter, Pseudomonas, Delftia, Shewanella, and Rheinheimera. The antibiotic resistance phenotypes of these isolates were determined (27 tested antibiotics-discs). All the studied isolates were found resistant to amoxicillin and gentamicin, and 83.33% of isolates were resistant to ciprofloxacin. Multiple antibiotic resistances were revealed against β-lactams, quinolones, and aminoglycosides families. Our overall results suggest that the obtained bacterial isolates may constitute potential candidates for bioremediation and can be useful for biotechnological applications. Genotoxic effects were assessed by a battery of biotests; the pharmaceutical wastewater was genotoxic according to the bacterial Vitotox test and micronuclei test. Genotoxicity was also evaluated by the comet test; the tail DNA damages reached 38 and 22% for concentrated sample (10×) and non-concentrated sample (1×), respectively. However, the histological sections of kidney and liver’s mice treated by pharmaceutical effluent showed normal histology and no visible structural effects or alterations as cytolysis, edema, or ulcerative necrosis were observed. Residual antibiotics can reach water environment through wastewater and provoke dissemination of the antibiotics resistance and induce genotoxic effects.
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Avoid common mistakes on your manuscript.
Introduction
Antibiotic residues can reach the environment through wastewater discharges (Heberer 2002; Yan et al. 2013). Wastewater treatment plants, pharmaceutical companies, and aquaculture activities are the sources of the aquatic antibiotic contamination (Adelowo et al. 2008; Baquero et al. 2008; Drewnowski and Makinia 2014; Hockenreiner et al. 2015). Antibiotics used in human medicine and animal use are not completely metabolized (Rang et al. 2003) and these active products can easily reach the sewage treatment systems. Since limitations were noted for the complete elimination of antibiotics residues in the process of conventional wastewater treatment, special attention was accorded to the evaluation of the environmental antibiotics risks (Czekalski et al. 2012; Novo et al. 2013; Varela et al. 2014).
Antibiotic residues at trace levels may be harmful due to their intrinsic biological activity, even after chronic exposure (Hernando et al. 2006). Perturbations in the productivity, disturbances of the ecosystem and biodiversity, and food chain disruptions may take place as a result of the abnormal physiological and biochemical functions of some major primary and secondary producers touched by antibiotics contamination (Halling-Sorensen 2000; Wollenberger et al. 2000). Another major issue is that the exposure to a contaminated effluent highly loaded with antibiotics helps to spread the resistance genes in environmental bacterial communities (Chen et al. 2013; De Castro et al. 2014; Kristiansson et al. 2011). Induction of resistance is possible even at low concentrations (Gullberg et al. 2011). The massive and uncontrolled use of antibiotics can lead to the spreading of incurable diseases caused by resistant bacteria (Solomons 1978) and aggravate the situation of immune-compromised persons (Allen et al. 2010; Canton 2009; De Costa et al. 2011).
To address such problems, genotoxicity tests using bacteria, plant, and animal cells have been developed (Ma et al. 2012; Mater et al. 2014; Zegura et al. 2009).
The combination of analytical chemistry and biological methods is advisable to predict the complex toxicological effects of compounds in the environment. The aim of this work is to determine the levels of the antibiotics residues in pharmaceutical effluent samples by LC MSMS, to study the resistant bacteria community in the effluent, and to assess cytotoxic and genotoxic effects of pharmaceutical effluent by a battery of biotests.
Materials and methods
Pharmaceutical effluent sampling
Pharmaceutical effluent samples were collected from a pharmaceutical industry located in Zaghouen (Tunisia). During 3 months (February, March, and April 2013), wastewaters were sampled before the discharging point using an instantaneous sampling. The samples were collected in autoclaved glass bottles and immediately transported to the laboratory and kept in the dark at 4 °C until microbiological, chemical, and toxicological testing.
Analytical methodology
UPLC-MS/MS analysis was performed to determine 56 antimicrobial drugs in the pharmaceutical effluents. After spiking with appropriate internal standards, a 100 mL aliquot was concentrated on an Oasis® HLB cartridge. After elution, drying, and reconstitution, an 8ùL aliquot was injected for analysis. UPLC-MS/MS analysis was performed using a Waters Acquity UPLC® system interfaced with a Xevo TQ-S tandem quadrupole mass spectrometer, all from Waters (Milford, MA, USA). Compounds were separated on an Acquity UPLC® BEHC18 column (100 × 2.1 mm) using 0.1% formic acid in water and in acetonitrile as mobile phase. Chromatography was performed within 12 min using a gradient elution.
Microbial study
Culture-independent approach: DGGE analysis
Total DNA was extracted from pharmaceutical wastewater and stored at − 20 °C. The denaturing gradient gel electrophoresis (DGGE) was performed on the 16S rDNA hypervariable V3–V5 regions. The primers 907 R (5′-CCGTCAATTCCTTTGAGTTT-3′) and 357F (5′-CTACGGGAGGCAGCAG-3′) were used for PCR. The primer 357F was enriched with an additional 40 bp GC-rich sequence (GC-clamp sequence) to avoid the complete strand separation. The PCR program included an initial denaturing step at 94 °C for 4 min, 10 cycles of 94 °C for 30 s, 61 °C for 1 min, and 72 °C for 1 min, 20 cycles of 94 °C for 30 s, 56 °C for 1 min, and 72 °C for 1 min, and a final extension at 72 °C for 1 min. PCR products were resolved on 6% (w/v) polyacrylamide gels in 1X TAE [20 mM Tris, 10 mM acetate, 0.5 mM EDTA (pH 7.4)] using a denaturing gradient ranging from 40 to 60% (where 100% denaturant contained 7 M urea and 40% formamide) (Ettoumi et al. 2010). Gels were run at 100 V for 17 h at 60 °C. An ethidium bromide solution (0.5 mg L−1) was used for staining the agarose and polyacrylamide, respectively, for 10 and 30 min. The gels were washed with sterile distilled water and immediately photographed with a digital capture system (GelDoc Cleaver).
Culture-dependent approach
Enumeration of antibiotic-resistant bacteria in the pharmaceutical effluent
Enumeration of antibiotic-resistant bacteria was carried out using the membrane filtration method which is described by Novo and Manaia (2010). The respective antibiotic-resistant populations were enumerated on the media supplemented with 32 mg L−1 of amoxicillin (AMX) or 4 mg L−1 of ciprofloxacin (CIP); β-lactams and quinolones are the only two antibiotics families produced by this industry.
Volumes of 1–100 mL (culture medium with antibiotic) and of 1–10 mL of water samples or decimal dilutions thereof (culture medium without antibiotic) were filtered through cellulose nitrate membranes (0.45 µm pore size, 47 mm diameter, Albet), which were placed onto the culture medium described above and incubated for 48 h at 30 °C. All analyses were made in triplicate. After 2 days of incubation, the number of colony forming units (CFU) was determined on the basis of filtering membranes containing between 10 and 100 CFU.
Isolation and selection of antibiotic-resistant bacteria
According to the method described by Sturm (1973), bacteria were isolated from one wastewater sample (similar chemical composition of wastewaters) using the mineral medium composed with (mg L−1): KH2PO4, 85; K2HPO4, 208; Na2HPO4.2H2O, 334; NH4Cl, 5; CaCl2, 27.5; MgSO4, 7H2O, 22.5; FeCl3, 6H2O, 0.25, the pH was adjusted to 7 supplemented with 1% of effluent and 1% of antibiotic solution (4 mg L−1 of ciprofloxacin and 32 mg L−1 of amoxicillin were added separately) as the sole carbon source. Flasks were incubated for 3 weeks at 30 °C on rotary shaker at 200 rpm. The isolated bacteria were identified basing on the analysis of the 16S rRNA gene sequence and using the primers 27F and 1492R (Lane 1991). After a serial dilution in mineral medium, individual colonies were selected and purified by repeated streaking on culture medium containing; mineral medium and 1% of antibiotic solution. Genomic DNA from pure strains was extracted by sodium dodecyl sulfate (SDS)-proteinase K treatment (Ettoumi et al. 2010). Molecular amplification of the 16S-23S ITS region and the 16S rRNA gene were performed using, respectively, the universal primers S-D-Bact-1494-a-20, L-D-Bact-0035-a-15 and 50-S-D-Bact-0008-a-S-20-30 and 50-S-D-Bact-1495-a-S-20-30. The TS sequences are highly conserved in the areas encompassing the rRNA genes and relatively stable regions located at the ends of the spacer (Daffonchio et al. 2000). The amplification reaction mixture consisted of 1 × PCR reaction buffer, 2.5 mM MgCl2, 0.12 mM deoxynucleoside triphosphate, 0.2 mM of each primer, 1 U Taq DNA polymerase, and 1 mL of total DNA. The PCR program consisted of an initial step at 94 °C for 3 min, 35 cycles of denaturation at 94 °C for 45 s, annealing for 1 min at 55 °C and elongation for 2 min s at 72 °C, followed by final elongation step at 72 °C for 8 min. The ITS-PCR amplification patterns and 16S products were migrated, respectively, on standard 2% agarose gels in 0.5 × Tris-borate-EDTA buffer and stained for 30 min in 0.5 mg L−1 ethidium bromide solution. The amplified 16S rRNA fragments were sequenced and identified by comparison with those available at the National Centre for Biotechnology Information (NCBI) database (http://www.ncbi.nlm.nih.gov) using the BLAST program (Altschul et al. 1990). A phylogenetic dendrogram was constructed by the neighbor joining method and a tree topology was evaluated by performing boot-strap analysis of 1000 data sets using MEGA 4.1 (Kumar et al. 2004).
Determination of antibiotic resistance profiles
Antibiotic resistance patterns were performed on Mueller–Hinton agar plates using the agar disc-diffusion method according to CLSI criteria (2007) (CLSI 2007). Twenty-seven antimicrobial agents were tested (µg/disc): nalidixic acid (30), ciprofloxacin (5), amoxicillin (25); ticarcillin (75); cephalothin (30); ceftazidime (30); streptomycin (10); sulphamethoxazole/trimethoprim (1.25/23.75); tetracycline (30); gentamicin (15); colistin sulfate (50); tobramycin (10); amoxicillin/clavulanic acid (20/10); piperacillin (75); cefotaxime (30); penicillin (6); oxacillin (5); erythromycin (15); spiramycin (100); cefoaxime (30); imipenem (10); ertapenem (10); levofloxacin (5); tigecycline (15); amikacin (30); ticarcillin/clavulanic acid (75/10); ofloxacin (5). For the antibiotics amoxicillin and colistin sulfate, which are not included in the CLSI list, the following criteria were used: S ≥ 21/R < 14 and S ≥ 10/R < 10, respectively. Escherichia coli ATCC 25,922 and Pseudomonas aeruginosa ATCC 27,853 were used as a control strains.
Toxicological study
Cell culture
Human hepato-cellular liver carcinoma cells (C3a) were grown in Dulbecco’s modified Eagle’s culture medium (DMEM) supplemented with 10% fetal calf serum and antibiotics (1% penicillin–streptomycin). The cultures were incubated in humidified atmosphere conditions with 5% CO2 at 37 °C. Every 4 days, the cultures were trypsinized and divided into 100 000 cells per Petri dish of 35 mm diameter with 10 mL of culture medium. A bath of Milli-Q water was also used to preserve humidity.
Concentration of samples
A 100 mL of water samples was concentrated on the previously preconditioned Oasis® HLB cartridge. After the drying process, the analytes were eluted and evaporated to dryness. Then, the concentrated residues were mixed with Milli-Q water so as to obtain the four dilutions and they were analyzed with the comet assay and the micronuclei test. Thus, the tested concentrations were 1×, 2.5×, 5× and 10×.
Vitotox test
The test is performed with Salmonella Typhimurium TA104 that is genetically modified and it shows DNA damage by emitting a readily detectable signal of bioluminescence after exposure to mutagenic factors (Verschaeve et al. 1999). This is made possible by the insertion of a luciferase gene (the lux operon of Vibrio fischeri) under transcriptional control of a mutated recN gene (TA104 recN2-4 or Genox strain). A second control strain (TA104 pr1 or Cytox strain) was also used. In this case, lux expression was independent of DNA damage and the light production increase was not the direct result of DNA damage, whereas the decreased light production reflected toxicity. Overnight bacteria cultures were conducted for the both Genox and Cytox strains in rich medium containing 625 µL of tetracycline (0.8 mg mL−1) and 312.5 µL of ampicillin (8 mg mL−1). Cultures were placed in a water bath of 36 °C for 16 h at 300 rpm. After the overnight incubation, the cultures were placed on ice for 15 min. 20 mL of mineral medium and 160 µL of previously cultured bacteria were added and stirred during 1 h in an appropriate water bath (300 rpm, 36 °C). The Genox and Cytox work cultures are ready for testing; a mixture of 2.125 mL of mineral medium, 350 µL of bacterial suspension, and 1 mL of S9 was prepared and transferred to a black 96-well microplate with 100 µL from each sample. When the S9 is not used in the test, we added 1 mL of mineral medium. Positive controls were used; 4-NQO (0.4 mg mL−1) tested without S9 and B(a)P (0.8 mg mL−1) tested with S9.
A microplate luminometer was used to measure genotoxicity and toxicity and the light was analyzed every 5 min over a 4-h time span. The signal-to-noise ratio (S/N) represents the calculation of the exposed bacteria light production divided by non-exposed bacteria light production for each measurement and for each strain separately. All the calculations were done automatically and they were based on measurements taken between 60 and 240 min of incubation. The previous experiments have demonstrated that genotoxicity always take place when the maximum S/N (genox)/max S/N(cytox) is greater than 1.5 and cytotoxicity is assumed when S/N in Genox/Cytox decreases far below 0.8 (Verschaeve et al. 1999, 2012; Verschaeve 2002).
Comet assay
The genotoxicity of a tested substance was valued by the determination of DNA damages in the comet tail. This test was conducted according to standard procedures (Fairburn et al. 1995; Tice et al. 2000). Four dilutions of wastewaters were tested on C3a cells. For this, 4 × 105 cells were seeded into 24-well plates and incubated at 37 °C (5% CO2) overnight. The culture medium was also removed, and the wastewater samples was then added and incubated again overnight at the same conditions. Ethyl methanesulfonate (EMS) (0.75 mM) was deployed as the positive control, whereas unexposed cells controls were also included as negative control.
In the next step, 75 µL of a cell-LMP suspension (0.8% low melting point agarose) was laid on the slides that had been previously frosted and then coated with 1% NMP (normal melting point agarose) and eventually they were left to dry. A lysis buffer (2.5 M NaCl; 100 mM EDTA; 10 mM TRIS) was used for cellular lysis. Alkali unwinding of the DNA was realized through the slides incubation in electrophoresis buffer (0.3M NaOH, 1 mM EDTA) for 40 min in a horizontal electrophoresis unit, and then, a neutralization with a Tris buffer (0.4 M, pH 7.5) and an electrophoresis (20 min, 1 V/m, 300 mA) were conducted. So as to stain DNA, a DAPI (fluorescent dye) was used, and finally, the analysis of the slides was carried out with an Axio Imager.Z2 (Zeiss) fluorescence microscope with Metacyte and Metafer 4 (version 3.8.5) software from Metasystems (Altlussheim, Germany) to quantify DNA damage. Two gels were prepared for each concentration along with the analysis of 50 cells per gel. Furthermore, the DNA percentage in the comet tail was considered to measure the DNA damage. Comet assay data (tail intensity) of wastewater exposed and control cells were compared with the Mann–Whitney U test.
Micronucleus test
The micronucleus assay determines the DNA damaging capacity of substances by the micronucleus formation after treatment of cells with the potentially mutagenic agent in culture. The micronucleus rate, which represents either chromosome fragments or a whole chromosome, requires cell division to be formed and is taken as an indicator for the DNA damaging capacity of the tested substance (Fenech and Crott 2002).
The human line C3a cells were trypsinized, seeded in 24-well plates (2 × 105 cell/well), and incubated overnight at 37 °C (5% CO2). The cells were exposed to four dilutions (previously described) of pharmaceutical effluent and cultivated again overnight at 37 °C (5% CO2). Methyl methanesulfonate (MMS) was used as a positive control and unexposed cells as the negative control. After an overnight exposure, the medium was withdrawn and replaced by a medium containing cytochalasin B (4.5 µg mL−1). Cells were fixed with a fresh cold solution of methanol and acetic acid (3/1) (v/v). The tubes containing the cells were kept well closed at − 20 °C for at least one night before spreading on slides. A DAPI DNA-staining was used to visualize under Zeiss light microscope and the acridine orange to visualize the cell shape. Per dilution, 2 × 103 C3a cells were scored. The cytochalasin B proliferation index (CBPI) was calculated as: CBPI = (1x mononuclear cells + 2x binucleated cells + 3x polynucleated cells)/total number of cells (Kirsch-Volders et al. 2003). Kastenbaum and Bowman tables were used for the analysis of the micronucleus results (Kastenbaum and Bowman 1970).
Histological study
The BALB/C mice used in the experiments were female about 10 weeks (weight ≈ 30 g) obtained from the Pasteur Institute in Tunis. The mice were grouped in ten per cage. They were synchronized for 15 days in a clean room with an alternating cycle: 12 h of light and 12 h of dark. The room temperature was maintained at 22 °C and a relative humidity of 50%. Mice were treated by intraperitoneal injection with a dose of 10 mL/kg to test the pharmaceutical effluent. The doses tested are previously determined sublethal. The ultrapure water sterilized by autoclaving was used as negative control.
Group 1: contains ten mice treated by intraperitoneal injection of a dose of 10 mL kg−1 of wastewater collected from pharmaceutical industry.
Group 2: contains ten mice treated by intraperitoneal injection of a dose of 10 mL kg−1 of ultrapure water sterilized by autoclaving. This group constitutes the negative control of the experiment.
Livers and kidneys were collected from mice for histological study. The sections were stained with haematoxylin–eosin.
Results
UPLC-MS/MS analysis
Two antibiotics were detected and quantified in the water samples, i.e., norfloxacin at 226.7 ng mL−1 and spiramycin at 84.2 ng mL−1, and the presence of norfloxacin and spiramycin was noticed in the four effluent samples at different levels.
Microbiological study
Culture-independent approach
DGGE culture-independent technique was used to determine the bacterial community in pharmaceutical effluent sampled during 3 consecutive months. A noticeable diversity was observed by the analysis of the hypervariable region profiles of the 16S rRNA (V3–V5) on polyacrylamide denaturing gel (Fig. 1). The profiles can be divided into three parts, non-rich bands in GC part characterized with short migration (I), moderately rich in GC part characterized by medium migration (II), and in the third part, the bands are rich in GC and the migration is long (III). Most bands of amplified 16S rRNA were found in part III; this showed the high GC content in bacteria. We observed a large variability in DGGE bands intensities and in migration distances. A remarkable difference was noted between the three profiles representing the months of February, March, and April. Three bands (Bd1, Bd2, and Bd3) were chosen and identified by sequencing from the three wastewater DGGE profiles. The two DGGE Bd1 and Bd3 bands were identified as uncultured bacteria and the DGGE Bd3 was identified as Rhodocyclaceae bacterium (Table 1).
Isolation and selection of antibiotic-degrading bacteria
The cultivable-resistant bacteria were determined from pharmaceutical effluent in culture media supplemented separately with amoxicillin (AMX, 32 mg L−1) or ciprofloxacin (CIP, 4 mg L−1). The resistant bacteria community to ciprofloxacin was reduced compared to resistant bacteria community to amoxicillin, 2.33 × 102 CFU mL−1 and 5.33 × 102 CFU mL−1, respectively (Table 2).
Sixteen strains were isolated from pharmaceutical effluent collected in April on mineral medium supplemented with 1% of effluent and 1% of antibiotic solution (4 mg L−1 of ciprofloxacin and 32 mg L−1 of amoxicillin were added separately) as the sole carbon source. These antibiotic-resistant strains were identified by amplification of the ribosomal intergenic transcribed spacer between the 16S and the 23S rRNA genes (ITS-PCR). The ITS profiles showed reproducible patterns consisting of 1 to 4 bands ranging from 150 to 950 bp. Six different ITS haplotypes were produced (data not shown).The most represented pattern was haplotype H3, found in 4 isolates, and composed by two reproducible bands of 950 and 750 bp. The other ITS groups were found in two isolates. Six representative strains are selected from the different groups for the partial 16S rRNA gene sequencing. On the basis of BLAST analysis of 16S rRNA gene similarity, six different genera including Pseudomonas, Acinetobacter, Citrobacter, Shewanella (the most represented in our collection (43%)), Delftia, and Rheinheimera were identified (Table 3).
The susceptibility of the six haplotypes to 27 antimicrobial agents is shown in Table 4. A high level of resistance was detected to amoxicillin (100%), gentamicin (100%), and ciprofloxacin (83.33%). A medium level of resistance was observed to cephalothin (66.66%), ceftazidime, tobramycin and cefotaxime (33.33%), and ticarcillin (50%). Lower levels were detected to spiramycin, penicillin, oxacillin, amikacin, erythromycin, amoxicillin/clavulanic acid, and piperacillin (16.66%). All the studied isolates have not shown susceptibility to colistin sulfate, nalidixic acid, streptomycin, sulphamethoxazole/trimethoprim, tetracycline, imipenem, ertapenem, levofloxacin, tigecycline, and ofloxacin. An antibiotic multi-resistance phenotype was observed. Three dominated multi-resistance profiles were detected for all the identified strains against the families of β-lactams, quinolones, and aminoglycosides.
Toxicological study
Vitotox test
The results showed that the tested pharmaceutical effluent is screened genotoxic and the max Genox/Cytox ratio was greater than 4 (Table 5) and greater than the positive controls (4-NQO and B(a)P) values. Genotoxicity decreased with addition of S9 mix to reach 2.2. It should be noted that no reduction of bioluminescence was perceived in the Cytox strain, which indicated that the effluent is not cytotoxic.
Comet assay
The DNA damages in the comet tail were measured in 100 cells. The results for comet tail length showed significant differences (Mann–Whitney U test) between tested concentrations, negative control (unexposed cells), and positive control (EMS 0.5 mM) (Fig. 2). The pharmaceutical effluent samples showed a dose-dependent genotoxic effect with tail DNA contents reaching 38 and 22% for the concentrated sample (10X) and non-concentrated sample (1X). It can be seen that this test confirmed the Vitotox results found previously.
Micronuclei test
The micronucleus test results are showed in Table 6. It can be noted that the tested concentrations of pharmaceutical effluent were all genotoxic in a dose-dependent manner. Micronuclei in binuclear cells increased from 9.5 to 13 in non-concentrated sample and 10-× concentrated sample, respectively. The cytochalasin B proliferation index (CBPI) proportionally related to the detected number of micronuclei and reflects the degree of genotoxicity. For our pharmaceutical effluent, the CBPI rose from 1.2 to 1.59 for the non-concentrated sample and 10× concentrated sample, respectively.
Histological study
No significant difference was observed when compared histological sections of the mice’s kidney and liver slides treated with sterile deionized water (as a negative control) and slides treated with pharmaceutical industry. In this present research, histological sections of mice’s kidney and liver showed no visible structural effects or alterations as cytolysis, edema, fibrosis, or hemorrhagic necrosis (Fig. 3).
Discussion
The antibiotic consumption is increasing, and as a result, environmental residues are growing (Deschamps et al. 2012). Water is frequently contaminated by drug residues (Hussain et al. 2016). The detection and the quantification of antibiotics may be useful to understand the potential associated hazards. Many published studies have focused on the research of antibiotics in wastewaters (Dinh et al. 2011; Dorival-Garcia et al. 2013; Tahrani et al. 2016; Zhou et al. 2012).
The analysis for determination of residual levels of the 56 selected antibiotics by liquid chromatography mass spectrometry method operating in the positive ion mode ESI+ showed the presence of norfloxacin and spiramycin in the studied effluent. The study of Hussain et al. (2016) reported that the residual levels of ofloxacin, ciprofloxacin, and levofloxacin were found in the range 0–9.40 mg L−1 in the pharmaceutical wastewaters in Lahore (Pakistan) compared to the highest concentration of norfloxacin which was determined in our research (0.29 mg L−1) and the highest concentration was observed for ofloxacin from fluoroquinolones class as found in our study. This is consistent with reports by Collado et al. (2014) and Gros et al. (2010) who detected high levels of fluoroquinolones. The absence of other antibiotics could be due to the low solubility in the water. Their hydrophobic nature drives them to partition from water to particulate matter and sediments. A seasonal (Birosova et al. 2014; Li et al. 2011) and temporal (Musolff et al. 2009) differences in pharmaceutical wastewater concentrations were observed. Our research confirmed these differences and we have noted that in 3 months, the temperature increased between winter season and spring season, because there was no change in the production schedule of the pharmaceutical plant. The removal of these two antibiotics in the effluent by the industry was very low and these antibiotics reached the environment. The chemical properties/structures of antibiotics are the fundamental factor for efficient removal. In general, the removal efficiencies were observed for norfloxacin were approximately between 5 and 78% (Gulkowska et al. 2008). Macrolides antibiotics (spiramycin) demonstrated either mediocre removal or no elimination, and they are usually characterized by higher concentrations in effluent wastewaters. This study confirms results found by the previous researchers (Gobel et al. 2007; Gros et al. 2010). In some cases, an increase in antibiotic concentrations in the final effluent was noted and this may be explained by two hypotheses, the first, it is due to the deconjugation reactions during the treatment process (Miao et al. 2002), and the second, it is due to the modifications in the molecules adsorption behavior during the treatment processes (Lindberg et al. 2005).
It is well known that pharmaceutical industries contributed to the aquatic pollution by discharging contaminants. The studied industry is located in a non-urban area and releases their discharges directly into a ditch in contact with animals and plants. Moreover, the pharmaceutical wastewater discharges join the river Maliane around 1 km far of the industry. Dumping of untreated pharmaceutical wastewater constitutes an incontestable environmental threat (Rao et al. 2001). 95% of antibiotic molecules may be released unchanged into the wastewaters treatment plants and they can later reach the aquatic environment. Microbial community represents the first natural target of the antibiotic contamination (Goni-Urriza et al. 2000; Halling-Sorensen et al. 1999). As reported in the studies of Li et al. (2011) and Novo et al. (2013), bacteria community’s dynamics depends on the geo-physical conditions such as temperature, pH, light, and flow (Hall et al. 2008; Sigee 2005; Zhang et al. 2011). The Rhodocyclaceae bacterium identified by DGGE technique in the studied effluent sampled in March is characterized by very versatile metabolic capabilities and degrades a wide range of carbon sources; this species lives in aquatic habitats and prefers oligotrophic conditions, occurs in waste water, and plays an important role in biological remediation at contaminated sites by polycyclic aromatic hydrocarbons (Oren 2014; Singleton et al. 2015). The DGGE showed the rearrangements of the aquatic bacterial populations in correlation with the variations of antibiotics levels in the investigated industrial pharmaceutical effluent.
In the previous studies of Lateef in 2003 and Tahrani et al. (2015), the resistant bacteria found per millimeter of pharmaceutical effluent were higher than those presented in this study. Some isolates (Acinetobacter, Citrobacter, and Shewanella) are potential pathogens capable of causing a variety of diseases in the respiratory and gastrointestinal tracts, infections in the urinary and hepatobiliary tracts, meningitis, bacteremia, otitis, soft-tissue infection (Albrecht et al. 2006; Ohara et al. 2000; Oh et al. 2008). In one hand, the isolation of pathogens from the pharmaceutical effluent is worrisome, but in the other hand, this may be an interesting result, because these pathogens are able to use the antibiotics as sole carbon source in the growth medium and subsequently a degradation of these micropollutants. Many previous studies have focused on the biodegradation of antibiotics with bacteria and optimization of the optimal conditions for this biodegradation (Dhall et al. 2012; Frank-Peterside et al. 2011; Ibegbulam-Njoku et al. 2013).
As reported in the previous studies, antibiotic contamination promoted the spreading of resistance and even multi-resistance of pathogens (Baquero et al. 2013; Gillings 2013). Human health can be also affected (Daughton and Ternes 1999; Martinez 2009; Tennstedt et al. 2005; Watkinson et al. 2007; Zhang et al. 2009).
Resistant bacteria in contaminant environmental water with antibiotics have been identified in several studies (Birosova et al. 2014; Figueira et al. 2011; Marti et al. 2014; Pei et al. 2006). Bacteria in these polluted aquatic matrices share or exchange transferable elements of DNA with other bacteria, this can occur between different bacterial species (Amos et al. 2014; Kaplan et al. 2013; Marti et al. 2014). The presence of antibiotic residues in the environment imposes selective forces for the emergence of antibiotic-resistant pathogens (Bengtsson-Palme and Larsson 2016). Eventually, some pathogens are related with confirmed or suspected nosocomial agents and infectious diseases. Furthermore, the resistant bacteria could find their way into drinking waters and food chain (Watkinson et al. 2007). It is a worldwide health threat which results in 700 000 deaths every year (Bengtsson-Palme and Larsson 2016). The ecological explanation of antibiotic resistance is the adaptation of the bacteria in the polluted environment (Finley et al. 2013; Pruden et al. 2013). Antibiotics such as fluoroquinolones provoke horizontal gene exchanges of resistance between bacterial community members, effects that could be detected even at low concentrations (Beaber et al. 2004; Larsson et al. 2007). Resistance is encoded by genes located in chromosomes and in extra-chromosomal materials. The cell division and the conjugation insure the passage of the resistance to the next generation between bacterial populations (Schluter et al. 2007; Wellington et al. 2013). In several studies, the multi-resistance phenomena were detected in aquatic environment containing synthetic antibiotics or modified molecules (Ash et al. 2002; Watkinson et al. 2007).
No alterations were noted by the histological study and the effects of the studied effluent were ultra-structural and non-visible or detectable in histological plan. However, the pharmaceutical effluent showed a genotoxic effect. Three toxicological tests: Vitotox, comet, and micronucleus assays were used and they were performed by microorganisms and eukaryote cells. The comet assay was often used, because this indicator test can be applied on wastewaters and it may reveal DNA damages induced by different mechanisms (Kudlak et al. 2016; Sharif et al. 2016). Finally, the micronucleus test is deployed, because it determines both structural and numerical chromosome aberrations and is currently considered one of the most significant and reliable genotoxicity tests (Kaur and Dua 2016; Kirsch-Volders et al. 2011; Parolini et al. 2016). The presence of antibiotics residues in the environment can pose serious health problems (Kungolos et al. 2006; Zegura et al. 2009). Hazardous effects were reported in several studies (Hernando et al. 2006; Sarmah et al. 2006). Maranho et al. (2014) demonstrated that pharmaceutical pollutants can alter aquatic organisms and distort the natural functions. Antibiotics are used to treat a number of human and animal infections (Verschaeve et al. 1999). Nevertheless, when they reach the aquatic environment they ended up being able to provoke genotoxicity in a genetically modified bacterial strain of Salmonella Typhimurium (Hartmann et al. 1998). Both eukaryotic tests (micronucleus and comet) confirm the results found by the prokaryotic test Vitotox in this research. The obtained results are interesting; insofar bioassays based on cells can provide a complete profile of the biological activities of chemical mixtures, as revealed in the study of Escher and Leusch (2012).
This research was not focused on the toxic activities of each molecule separately, but in the aquatic environment, molecules are present as mixtures of various therapeutic classes and the determination of toxic impact should take in consideration these pharmaceutical cocktails (Pomati et al. 2008). Numerous previous researches demonstrated that environmental cocktails elicited toxic alterations when an individual molecule proved not toxic (Cleuvers 2003, 2004). The toxic effect could be due to the formation of residues in the treatment processes. Indeed, many technologies used in municipal treatment such as disinfection by chlorination or UV irradiation, ultrafiltration, reverse osmosis, and ozone are able to induce genotoxic compounds (Bourgeous et al. 2001; Qin et al. 2005; Takanashi et al. 2009). As reviewed in the study of Mathur et al. (2007) that biological treatment can produce new mutagens.
Conclusion
The presence of the antimicrobial drugs in the pharmaceutical effluent, which reaches environment as an emerging environmental pollutant, leads to the spreading of the resistant pathogens and the alteration of the microbial diversity. Genotoxic effects on prokaryotes and eukaryotes were also noted in this study. The treatment processes adopted by the studied pharmaceutical industry were not efficient enough, since residues of antibiotics were detected in the outgoing wastewater of the industry. The antibiotic-degrading isolates may be used for the bioremediation in contaminated aquatic environment.
References
Adelowo O, Fagade O, Oke AJ (2008) Prevalence of co-resistance to disinfectants and clinically relevant antibiotics in bacterial isolates from three hospital laboratory wastewaters in southwestern Nigeria. World J Microbiol Biotechnol 25:1993–1997
Albrecht MC, Griffith ME, Murray CK, Chung KK, Horvath EE, Ward JA, Hospenthal DR, Holcomb JB, Wolf SE (2006) Impact of acinetobacter infection on the mortality of burn patients. J Am Coll Surg 203:546–550
Allen HK, Donato J, Davies J, Wang HH, Handelsman J (2010) Call of the wild: antibiotic resistance genes in natural environments. Nat Rev Microbiol 8:251–259
Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ (1990) Basic local alignment search tool. J Mol Biol 215:403–410
Amos GC, Hawkey PM, Gaze WH, Wellington EM (2014) Waste water effluent contributes to the dissemination of CTX-M-15 in the natural environment. J Antimicrob Chemother 29:1785–1791
Ash RJ, Mauck B, Morgan M (2002) Antibiotic resistance of Gram-negative bacteria in rivers, United States. Emerg Infect Dis 8:713–716
Baquero F, Martinez JL, Canton R (2008) Antibiotic and antibiotic resistance in water environments. Curr Opin Biotechnol 19:260–265
Baquero F, Tedim AP, Coque TM (2013) Antibiotic resistance shaping multi-level population biology of bacteria. Front Microbiol 4:15. https://doi.org/10.3389/fmicb.2013.00015
Beaber JW, Hochhut B, Waldor MK (2004) SOS response promotes horizontal dissemination of antibiotic resistance genes. Nature 427:72–74
Bengtsson-Palme J, Larsson DG (2016) Concentrations of antibiotics predicted to select for resistant bacteria: proposed limits for environmental regulation. Environ Int 86:140–149
Birosova L, Mackulak T, Bodak I, Ryba J, Skuback J, Grabic R (2014) Pilot study of seasonal occurrence and distribution of antibiotics and drug resistant bacteria in wastewater treatment plants in Slovakia. Sci Total Environ 490:440–444
Bourgeous KN, Darby JL, Tchobanoglous G (2001) Ultrafiltration of wastewater: effects of particles, mode of operation, and backwash effectiveness. Water Res 35:77–90
Canton R (2009) Antibiotic resistance genes from the environment: a perspective through newly identified antibiotic resistance mechanisms in the clinical setting. Clin Microbiol Infect 15:20–25
Chen B, Yang Y, Liang X, Yu K, Zhang T, Li X (2013) Metagenomic profiles of antibiotic resistance genes (ARGs) between human impacted estuary and deep ocean sediments. Environ Sci Technol 47:12753–12760
Cleuvers M (2003) Aquatic ecotoxicity of pharmaceuticals including the assessment of combination effects. Toxicol Lett 142:185–194
Cleuvers M (2004) Mixture toxicity of the anti-inflammatory drugs diclofenac, ibuprofen, naproxen and acetylsalicylic acid. Ecotoxicol Environ Saf 59:309–315
CLSI (2007) Clinical and Laboratory Standards Institute (CLSI), M100-S17. Performance Standards for Antimicrobial Susceptibility Testing, vol 27, (Wayne, PA)
Collado N, Rodriguez-Mozaz S, Gros M, Rubirola A, Barcelo D, Comas J, Rodriguez-Roda I, Buttiglieri G (2014) Pharmaceuticals occurrence in a WWTP with significant industrial contribution and its input into the river system. Environ Pollut 185:202–212
Commission Decision of 2002/657/EC implementing Council Directive 96/23/EC concerning the performance of analytical methods and the interpretation of results, Off J Eur Commun. 17/08/2002, No. L221/pp 8–36
Czekalski N, Berthold T, Caucci S, Egli A, Burgmann H (2012) Increased levels of multiresistant bacteria and resistance genes after wastewater treatment and their dissemination into Lake Geneva, Switzerland. Front Microbiol 3:1–18
Daffonchio D, Cherif A, Borin S (2000) Homoduplex and heteroduplex polymorph-isms of the amplified ribosomal 16S–23S internal transcribed spacers describe genetic relationships in the ‘‘Bacillus cereus group’’. Appl Environ Microbiol 66:5460–5468
Daughton CG, Ternes TA (1999) Pharmaceuticals and personal care products in the environment: agents of subtle change? Environ Health Perspect 107:907–938
De Costa VM, King CE, Kalan L, Morar M, Sung WW, Schwarz C, Froese D, Zazula G, Calmels F, Debruyne R, Golding GB, Poinar HN, Wright GD (2011) Antibiotic resistance is ancient. Nature 477:457–461
De Castro A, Fenandes G, Franco O (2014) Insights into novel antimicrobial compounds and antibiotic resistance genes from soil metagenomes. Front Microbiol 5:489–498
Deschamps E, Vasconcelos O, Lange L, Donnici CL, Da Silva MC, Sales JA, (2012) Management of effluents and waste from pharmaceutical industry in Minas Gerais, Brazil. Brazil J Pharm Sci 48
Dhall P, Kumar R, Kumar A (2012) Biodegradation of sewage wastewater using autochthonous bacteria. Sci World J. https://doi.org/10.1100/2012/861903 (ID861903)
Dinh QT, Alliot F, Moreau-Guigon E, Eurin J, Chevreuil M, Labadie P (2011) Measurement of trace levels of antibiotics in river water using on-line enrichment and triple quadrupole LC–MS/MS. Talanta 85:1238–1245
Dorival-Garcia N, Zafra-Gomez A, Cantarero S, Navalon N, Vilchez JL (2013) Simultaneous determination of 13 quinolones antibiotic derivatives in wastewater samples using solid-phase extraction and ultra performance liquid chromatography–tandem mass spectrometry. Microchem J 106:323–333
Drewnowski J, Makinia J (2014) The role of biodegradable particulate and colloidal organic compounds in biological nutrient removal activated sludge systems. Int J Environ Sci Technol 11:1973–1988
Escher B, Leusch F (2012) Bioanalytical tools in water quality assessment. IWA Publishing, London
Ettoumi B, Bouhajja E, Borin S, Daffonchio D, Boudabous A, Cherif A (2010) Gamma-proteobacteria occurrence and microdiversity in Tyrrhenian Sea sediments as revealed by cultivation-dependant and independent approaches. Syst Appl Microbiol 33:222–231
Fairburn DW, Olive PL, O’Neill KL (1995) The comet assay: a comprehensive review. Mutat Res 339:37–59
Fenech M, Crott JW (2002) Micronuclei, nucleoplasmic bridges and nuclear buds induced in folic acid deficient human lymphocytes-evidence for breakage-fusion-bridge cycles in the cytokinesis-block micronucleus assay. Mutat Res 504:131–136
Figueira V, Vaz-Moreira I, Silva M, Manaia CM (2011) Diversity and antibiotic resistance of Aeromonas spp. in drinking and waste water treatment plants. Water Res 45:5599–5611
Finley RL, Collignon P, Larsson DG, McEwen SA, Li XZ, Gaze WH, Reid-Smith R, Timinouni M, Graham DW, Topp E (2013) The scourge of antibiotic resistance: the important role of the environment. Clin Infect Dis 57:704–710
Frank-Peterside N, Peekate L, Oriakpono O (2011) Degradation of antibiotics by bacteria and fungi from the aquatic environment. J Toxicol Environ Health Sci 3:275–285
Gillings MR (2013) Evolutionary consequences of antibiotic use for the resistome, mobilome and microbial pangenome. Front Microbiol. https://doi.org/10.3389/fmicb.2013.00004
Gobel A, McArdell CS, Joss A, Siegrist H, Giger W (2007) Fate of sulfonamides, macrolides, and trimethoprim in different wastewater treatment technologies. Sci Total Environ 372:361–371
Goni-Urriza M, Capdepuy Arpin C, Raymond N, Caumette P, Quentin C (2000) Impact of an urban effluent on antibiotic resistant of riverine enterobacteriaceae and Aeromonas sp. Appl Env Microbiol 66:125–132
Gros M, Petrovic M, Ginebreda A, Barcelo D (2010) Removal of pharmaceuticals during wastewater treatment and environmental risk assessment using hazard indexes. Environ Int 36:15–26
Gulkowska A, Leung HW, So MK, Taniyasu S, Yamashita N, Yeung LWY, Richardson BJ, Lei AP, Giesy JP, Lam PKS (2008) Removal of antibiotics from wastewater by sewage treatment facilities in Hong Kong and Shenzhen, China. Water Res 42:395–403
Gullberg E, Cao S, Berg OG, Ilback C, Sandegren L, Hughes D, Andersson DI (2011) Selection of resistant bacteria at very low antibiotic concentrations. PLoS Pathog 1:7–9
Hall EK, Neuhauser C, Cotner JB (2008) Toward a mechanistic understanding of how natural bacterial communities respond to changes in temperature in aquatic ecosystems. ISME 2:471–481
Halling-Sorensen B (2000) Inhibition of aerobic growth and nitrification of bacteria in sewage sludge by anti-bacterial agents. Arch Environ Contam Toxicol 40:451–460
Halling-Sorensen B, Holten-Lutzhoft HC, Jorgensen SE (1999) Algal toxicity of antibacterial agents applied in Danish fish farming. Arch Environ Contam Toxicol 36:1–6
Hartmann A, Alder AC, Koller T, Widmer RM (1998) Identification of fluoroquinolone antibiotics as the main source of umuC genotixicity in native hospital wastewater. Environ Toxicol Chem 17:377–382
Heberer T (2002) Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data. Toxicol Lett 131:5–17
Hernando MD, Mezcua M, Fernandez-Alba AR, Barcelo D (2006) Environmental risk assessment of pharmaceutical residues in wastewater effluents, surface waters and sediments. Talanta 69:334–342
Hockenreiner M, Neugebauer H, Elango L (2015) Ex situ bioremediation method for the treatment of groundwater contaminated with PAHs. Int J Environ Sci Technol 12:285–296
Hussain S, Naeem M, Chaudhry MN (2016) Estimation of Residual Antibiotics in Pharmaceutical Effluents and their Fate in Affected Areas. Pol J Environ Stud 25:607–614
Ibegbulam-Njoku PN, Chijioke-Osuji CC, Imo EO (2013) Physicochemical characteristics and biodegradation of pharmaceutical effluent. Int J Sci Eng Res 4:29–38
Kaplan E, Ofek M, Jurkevitch E, Cytryn E (2013) Characterization of fluoroquinolone resistance and qnr diversity in Enterobacteriaceae from municipal biosolids. Front Microbiol 1–7
Kastenbaum MA, Bowman KO (1970) Tables for determining the statistical significance of mutation frequencies. Mutat Res 9:527–549
Kaur R, Dua A (2016) Fish liver and gill cells as cytogenotoxic indicators in assessment of water quality. Environ Sci Pollut Res 23:18892–18900
Kirsch-Volders M, Decordier I, Elhajouji A, Plas G, Aardema MJ, Fenech M (2011) In vitro genotoxicity testing using the micronucleus assay in cell lines, human lymphocytes and 3D human skin models. Mutagenesis 26:177–184
Kristiansson E, Fick J, Janzon A, Grabic R, Rutgersson C, Weijdegard B, Soderstrom H, Larsson DG (2011) Pyrosequencing of antibiotic-contaminated river sediments reveals high levels of resistance and gene transfer elements. PLoS One 6:e17038. https://doi.org/10.1371/journal.pone.0017038
Kudlak B, Wieczerzak M, Yotova G, Tsakovski S, Simeonov V, Namiesnik J (2016) Environmental risk assessment of Polish wastewater treatment plant activity. Chemosphere 160:181–188
Kumar S, Tamura K, Nei M (2004) MEGA3: integrated software for molecular evolutionary genetics analysis and sequence alignment. Brief Bioinform 5:150–163
Kungolos AG, Brebbia CA, Samaras CP, Popov V (2006) Environmental toxicology. Southampton, p. 362
Lane DJ (1991) 16S/23S rRNA sequencing. In: Stackebrandt E, Goodfellow M (eds) Nucleic acid techniques in bacterial systematics. Wiley, Chichester, pp 115–175
Larsson DG, Pedro C, Paxeus N (2007) Effluent from drug manufactures contains extremely high levels of pharmaceuticals. J Hazard Mater 148:751–755
Lateef A (2003) The Microbiology of a Pharmaceutical Effluent and Its Public Health Implications. World J Microb Bio 20:167–171
Li D, Qi R, Yang M, Zhang Y, Yu T (2011) Bacterial community characteristics under long-term antibiotic selection pressures. Water Res 45:6063–6073
Lindberg RH, Wennberg P, Johansson MI, Tysklind M, Andersson BAV (2005) Screening of Human Antibiotic Substances and Determination of Weekly Mass Flows in Five Sewage Treatment Plants in Sweden. Environ Sci Technol 39:3421–3429
Ma D, Hettiarachchi G, Nguyen D, Zhang B, Wittenberg JB, Zavalij PY, Briken V, Isaacs L (2012) Acyclic cucurbituril molecular containers enhance the solubility and bioactivity of poorly soluble pharmaceuticals. Nat Chem J 4:503–510
Maranho LA, Baena-Nogueras RM, Lara-Martín PA, DelValls TA, Martin-Diaz ML (2014) Bioavailability, oxidative stress, neurotoxicity and genotoxicity of pharmaceuticals bound to marine sediments. The use of the polychaete Hediste diversicolor as bioindicator species. Environ Res 134:353–365
Marti E, Variatza E, Balcazar JL (2014) The role of aquatic ecosystems as reservoirs of antibiotic resistance. Trends Microbiol 22:36–41
Martinez JL (2009) Environmental pollution by antibiotics and by antibiotic resistance determinants. Environ Pollut 157:2893–2902
Mater N, Geret F, Castillo L, Faucet-Marquis V, Albasi C, Pfohl-Leszkowicz A (2014) In vitro tests aiding ecological risk assessment of ciprofloxacin, tamoxifen and cyclophosphamide in range of concentrations released in hospital wastewater and surface water. Environ Int 63:191–200
Mathur N, Bhatnagar P, Mohan K, Bakre P, Nagar P, Bijarnia M (2007) Mutagenicity evaluation of industrial sludge from common effluent treatment plant. Chemosphere 67:1229–1235
Miao XS, Koenig BG, Metcalfe CD (2002) Analysis of acidic drugs in the effluents of sewage treatment plants using liquid chromatography–electrospray ionization tandem mass spectrometry. J Chromatogr A 952:139–147
Musolff A, Leschik S, Möder M, Strauch G, Reinstorf F, Schirmer M (2009) Temporal and spatial patterns of micropollutants in urban receiving waters. Environ Pollut 157:3069–3077
Novo A, Manaia CM (2010) Factors influencing antibiotic resistance burden in municipal wastewater treatment plants. Appl Microbiol Biotechnol 87:1157–1166
Novo A, Andre S, Viana P, Nunes OC, Manaia CM (2013) Antibiotic resistance, antimicrobial residues and bacterial community composition in urban wastewater. Water Res 47:1875–1887
Oh HS, Kum KA, Kim EC, Lee HJ, Choe KW, Oh MD (2008) Outbreak of Shewanella algaeand Shewanella putrefaciens infections caused by a shared measuring cup in a general surgery unit in Korea. Infect Control Hosp Epidemiol 29:742–748
Ohara CM, Brenner FW, Miller JM (2000) Classification, identification, and clinical significance of proteus, providencia, and morganella. Clin Microbiol Rev 13:534–546
Oren A (2014) The prokaryotes, the family Rhodocyclaceae. Springer, Berlin, pp 975–998
Parolini M, Magni M, Castiglioni S, Binelli A (2016) Genotoxic effects induced by the exposure to an environmental mixture of illicit drugs to the zebra mussel. Ecotoxicol Environ Saf 132:26–30
Pei R, Kim SC, Carlson KH, Pruden A (2006) Effect of River Landscape on the sediment concentrations of antibiotics and corresponding antibiotic resistance genes (ARG). Water Res 40:2427–2435
Pomati F, Orlandi C, Clerici M, Luciani F, Zuccato E (2008) Effects and interactions in an environmentally relevant mixture of pharmaceuticals. Toxicol Sci. 102:129–137
Pruden A, Larsson DG, Amézquita A, Collignon P, Brandt KK, Graham DW, Lazorchak JM, Suzuki S, Silley P, Snape JR, Topp E, Zhang T, Zhu YG (2013) Management options for reducing the release of antibiotics and antibiotic resistance genes to the environment. Environ Health Perspect 121:878–885
Qin JJ, Oo MH, Wai MN, Kekre KA (2005) TOC removal in reclamation of municipal wastewater by RO. SepPurif Technol 46:125–128
Rao V, Dhar RL, Subrahmanyam K (2001) Assessment of contaminant migration in groundwater from an industrial developpment area, Medak district, Andhra Pradesh. Water Air Soil Pollut 12:369–389
Sarmah AK, Meyer MT, Boxall AB (2006) A global perspective on the use, sales, exposure pathways, occurrence, fate and effects of veterinary antibiotics (VAs) in the environment. Chemosphere 65:725–759
Schluter A, Szczepanowski R, Kurz N, Schneiker S, Krahn I, Puhler A (2007) Erythromycin resistance-conferring plasmid pRSB105, isolated from a sewage treatment plant, harbors a new macrolide resistance determinant, an integron-containing Tn402-like element, and a large region of unknown function. Appl Environ Microbiol 73:1952–1960
Sharif A, Ashraf M, Anjum AA, Javeed A, Altaf I, Akhtar MF, Abbas M, Akhtar B, Saleem A (2016) Pharmaceutical wastewater being composite mixture of environmental pollutants may be associated with mutagenicity and genotoxicity. Environ Sci Pollut Res Int 23:2813–2820
Sigee DC (2005) Freshwater microbiology: biodiversity and dynamic interactions of microorganisms in the aquatic environment. Wiley, West Sussex
Singleton DR, Dickey AN, Scholl EH, Wright FA, Aitken MD (2015) Complete genome sequence of a novel bacterium within the family Rhodocyclaceae that degrades polycyclic aromatic hydrocarbons. Genome Announc. https://doi.org/10.1128/genomeA00251-15
Solomons IA (1978) Antibiotics in animal feeds Human and animal safety issues. J Ani Sci 46:1360–1368
Sturm RN (1973) Biodegradability of nonionic surfactants screening test for predicting rate and ultimate biodegradation. J Am Oil Chem Soc 50:159–167
Tahrani L, Soufi L, Mehri I, Najjari A, Hassan A, Van Loco J, Reyns T, Cherif A, Ben Mansour H (2015) Isolation and characterization of antibiotic-resistant bacteria frompharmaceutical industrial wastewaters. Microb Pathog 89:54–61
Tahrani L, Van Loco J, Ben Mansour H, Reyns T (2016) Occurrence of antibiotics in pharmaceutical industrial wastewater, wastewater treatment plant and sea waters in Tunisia. J Water Health 14:208–213
Takanashi H, Kishida M, Nakajima T, Ohki A, Akiba M, Aizawa T (2009) Surveying the mutagenicity of tap water to elicit the effects of purification processes on Japanese tap water. Chemosphere 77:434–439
Tennstedt T, Szczepanowski R, Krahn I, Puhler A, Schluter A (2005) Sequence of the 68,869 bp IncP-1alpha plasmid pTB11 from a waste-water treatment plant reveals a highly conserved backbone, a Tn402-like integron and other transposable elements. Plasmid 53:218–238
Tice RR, Agurell E, Anderson D, Burlinson B, Hartmann A, Kobayashi H, Miyamae Y, Rojas E, Ryu JC, Sasaki YF (2000) Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ Mol Mutagen 35:206–221
Varela AR, Andre S, Nunes O, Manaia C (2014) Insights into the relationship between antimicrobial residues and bacterial populations in a hospital-urban wastewater treatment plant system. Water Res 54:327–336
Verschaeve L (2002) Genotoxicity studies in groundwater, surface waters, and contaminated soil. Sci World J 2:1247–1253
Verschaeve L, Van Gompel J, Thilemans L, Regniers L, Vanparys P, Van der Lelie D (1999) VITOTOX® bacterial genotoxicity and toxicity test for the rapid screening of chemicals. Environ Mol Mutagen 33:240–248
Verschaeve L, Mertens B, Ndhlala AR, Anthonissen R, Gorissen B, Van Staden BJ (2012) Extracts from Hypoxis Species and a Commercially Available Hypoxis Preparation. Phytother Res 27:350–356
Watkinson AJ, Murbyc EJ, Costanzo SD (2007) Removal of antibiotics in conventional and advanced wastewater treatment: implications for environmental discharge and wastewater recycling. Water Res 41:4164–4176
Wellington EM, Boxall AB, Cross P, Feil EJ, Gaze WH, Hawkey PM, Johnson-Rollings AS, Jones DL, Lee NM, Otten W, Thomas CM, Williams AP (2013) The role of the natural environment in the emergence of antibiotic resistance in Gram-negative bacteria. Lancet Infect Dis 13:155–165
Wollenberger L, Halling-Soerensen B, Kusk KO (2000) Acute and chronic toxicity of veterinary antibiotics to Daphnia magna. Chemosphere 70:723–730
Yan C, Dinh QT, Chevreuil M, Garnier J, Roose-Amsaleg C, Labadie P, Laverman AM (2013) The effect of environmental and therapeutic concentrations of antibiotics on nitrate reduction rates in river sediment. Water Res 47:3654–3662
Zegura B, Heath E, Cernosa A, Filipic M (2009) Combination of in vitro bioassays for the determination of cytotoxic and genotoxic potential of wastewater, surface water and drinking water samples. Chemosphere 75:1453–1460
Zhang X, Zhang T, Fang HP (2009) Antibiotic resistance genes in water environment. Appl Micobiol Biotechnol 82:397–414
Zhang S, Yang G, Hou S, Wang Y (2011) Abundance and diversity of glacial bacteria on the Tibetan Plateau with environment. Geomicrobiol J 27:649–655
Zhou JL, Maskaoui K, Lufadeju A (2012) Optimization of antibiotic analysis in water by solid-phase extraction and high performance liquid chromatography-mass spectrometry/mass spectrometry. Anal ChimActa 731:32–39
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicated by Djamel DRIDER.
Rights and permissions
About this article
Cite this article
Tahrani, L., Mehri, I., Reyns, T. et al. UPLC-MS/MS analysis of antibiotics in pharmaceutical effluent in Tunisia: ecotoxicological impact and multi-resistant bacteria dissemination. Arch Microbiol 200, 553–565 (2018). https://doi.org/10.1007/s00203-017-1467-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00203-017-1467-x